- Report
- September 2025
- 21 Pages
Argentina
From €995EUR$1,182USD£883GBP
- Report
- September 2025
- 28 Pages
Australia
From €995EUR$1,182USD£883GBP
- Report
- September 2025
- 25 Pages
Austria
From €995EUR$1,182USD£883GBP
- Report
- September 2025
- 25 Pages
Austria
From €995EUR$1,182USD£883GBP
- Report
- September 2025
- 21 Pages
Argentina
From €995EUR$1,182USD£883GBP
- Report
- September 2025
- 28 Pages
Australia
From €995EUR$1,182USD£883GBP
- Report
- October 2024
- 23 Pages
Ukraine
From €995EUR$1,182USD£883GBP
- Report
- October 2024
- 24 Pages
Ukraine
From €995EUR$1,182USD£883GBP
- Report
- October 2024
- 21 Pages
Morocco
From €995EUR$1,182USD£883GBP
- Report
- October 2024
- 21 Pages
Morocco
From €995EUR$1,182USD£883GBP
- Report
- September 2024
- 18 Pages
Vietnam
From €995EUR$1,182USD£883GBP
- Report
- September 2022
- 111 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- November 2024
- 102 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- August 2023
- 142 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- September 2023
- 103 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- June 2023
- 99 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- October 2023
- 103 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- March 2022
- 80 Pages
Global
From €3500EUR$4,157USD£3,106GBP
- Report
- September 2026
- 45 Pages
Global
From €266EUR$295USD£228GBP
- Report
- September 2026
Global
From €3598EUR$3,990USD£3,086GBP

The AIDS market within the context of Allergy and Immunology is focused on the development of treatments and therapies for HIV/AIDS. This includes the development of drugs to treat HIV infection, as well as vaccines and other therapies to prevent the spread of the virus. Additionally, research is being conducted to better understand the mechanisms of HIV infection and the development of new treatments.
The market is highly competitive, with many companies vying for a share of the market. Companies such as Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and ViiV Healthcare are all major players in the AIDS market. Other companies such as AbbVie, Janssen, and Pfizer are also involved in the development of treatments and therapies for HIV/AIDS. Show Less Read more